Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles
Generally, patients with more severe patient-reported hair loss and ES/AL had decreased QoL and satisfaction with care and greater work productivity impairment. Although class 3 had moderate patient-reported hair loss, patients experienced the most severe ES/AL burden, suggesting that AA impacts well-being and daily activities in patients with less extensive hair loss.
Authors
- Samantha K. Kurosky (ORCID: https://orcid.org/0000-0003-2392-8111)
- Sergio Vañó‐Galván (ORCID: https://orcid.org/0000-0003-2773-7494)
- James Piercy (ORCID: https://orcid.org/0000-0001-7015-1021)
- Simran Marwaha (ORCID: https://orcid.org/0000-0003-0380-0372)
- Peter Anderson (ORCID: https://orcid.org/0000-0002-2171-8228)
- Nicola Clayton
- Ernest H. Law (ORCID: https://orcid.org/0000-0002-6111-8008)
- Alexandre Lejeune
- Kent A. Hanson (ORCID: https://orcid.org/0000-0002-7201-3324)
- Jenny Austin (ORCID: https://orcid.org/0000-0003-4297-6290)
Institutions
- Pfizer (United States) (US)
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- University of Illinois Chicago (US)
- Adelphi Group (United Kingdom) (GB)
- Pfizer (France) (FR)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-07-21
- DOI
- https://doi.org/10.1007/s12325-025-03302-8
- Citations
- 2
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.67
Funders
- Pfizer